MM
Mitul Manjibhai Sapara
About Mitul Manjibhai Sapara
Data last updated:
Mitul Manjibhai Sapara was a Director at Supal Pharmacare Limited (2024–2025), Director at Mono Pharmacare Limited (2023) and Director at Dls Export Corporation Private Limited (2021–2023), and held 2 more directorships. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Feb 2024 | 2023 | ₹33.91 Cr (FY 2024) | Active | |
| Director | 22 Mar 2023 | 2022 | ₹169 Cr (FY 2025) | Active | |
| Director | 23 Oct 2021 | 2021 | Strike Off | ||
| Director | 24 Dec 2020 | 2020 | ₹15.73 Cr (FY 2024) | Active | |
| Partner | 30 Dec 2022 | 2017 | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mitul Manjibhai Sapara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitul Manjibhai Sapara
Mitul Manjibhai Sapara was first appointed on 24 Dec 2020 as Director at Quealth Pharmaceutical Private Limited. The most recent appointment on record is 24 Feb 2024 at Supal Pharmacare Limited.
Mitul Manjibhai Sapara held 5 earlier board appointments: Supal Pharmacare Limited (Director, 24 Feb 2024 to 25 Oct 2025); Mono Pharmacare Limited (Director, 22 Mar 2023 to 16 Dec 2023); Dls Export Corporation Private Limited (Director, 23 Oct 2021 to 28 Feb 2023); Quealth Pharmaceutical Private Limited (Director, 24 Dec 2020 to 04 Dec 2022); Supal Medical & Wholesale Llp (Partner, from 30 Dec 2022).